Your Voice on the Future of Active Surveillance
Don't miss: Join us at 11 a.m. Eastern on April 22. Register before all seats are gone.
By Howard Wolinsky
Do you want to see where active surveillance is heading? Do you have some views you want to share?
Active Surveillance Patients International and the AnCan Virtual Support Group for Active Surveillance and other leading advocates and doctors are holding a webinar on this topic, "Your Voice in the Future of Active Surveillance," at 11 a.m.Eastern/4 p.m. GMT/5 p.m. CET.
Sign up here ASAP: https://zoom.us/meeting/register/tJEtfuuqrzwtHNPuqzkigx65YBk8vV-teUdy
This webinar is a spinoff from two projects held this winter to address the future of AS.
Movember, the Australia-based men’s health organization, and Prostate Cancer International/University of Maryland held programs engaging patients and doctors on future directions for AS.
The leaders in this work, Dr. Minhaj Siddiqui, Professor, Urology, the University of Maryland, and Dr. Caroline Moore, Professor, Urology, University College London Division of Surgery and Interventional Medicine, representing Movember, will present their research to date at the webinar.
Our panelists so far include:
--Dr. Chris Bangma, professor of urology at Erasmus Medical Center in Rotterdam, is a leader in the introduction of active surveillance in Europe. He is coordinator of PRIAS and GAP3 studies.
--Dr. Ola Bratt, professor and consultant urological surgeon at the Prostate Cancer Centre, Sahlgrenska University Hospital Gothenburg, Sweden, and chairman of the National Prostate Cancer Guidelines Group in Sweden.
—Dr. Peter Albertsen, a pioneer in active surveillance. is professor and chief of urology at the University of Connecticut.
—Dr. Peter Carroll, professor, UCSF Department of Urology, founded the Urologic Oncology Service at UCSF and is a pioneer in active surveillance.
—Dr. E. David Crawford, professor, the University of California, San Diego, a leader in researching molecular testing.
—Dr. Laurence Klotz, professor, University of Toronto, who named AS and has been a leader in its development.
—Dr. Antonio Westphalen, faculty member, University of Washington Departments of Radiology, Urology, and Radiation Oncology, and chief of the Abdominal Imaging Section.
—Dr. Timothy Wilt is a health services researcher at the Minneapolis VA Center whose work led to the development of observation, watchful waiting, and screening of prostate cancer.
In addition to ASPI and AnCan, program sponsors include Prostate Cancer Support Canada, the Prostate Forum of Orange County, the Walnut Foundation in Toronto, and TheActiveSurveillor.com newsletter.
Thank you Howard for all you do to educate all of us in how to be better advocates for our health care. I have felt challenged in obtaining objective advice and you provide it.